HPV prevalence and distribution characteristics in postmenopausal women from Nanjing, China
- PMID: 38267981
- PMCID: PMC10809476
- DOI: 10.1186/s12905-024-02904-8
HPV prevalence and distribution characteristics in postmenopausal women from Nanjing, China
Abstract
Background: Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021.
Methods: We retrospectively analyzed the data of 14,608 postmenopausal women aged 45-90 years, who underwent HPV examination in Nanjing First Hospital between January 2019 and December 2021. All participants were tested for 23 HPV genotypes. We subsequently analyzed the infection rate and evaluated the distribution of HPV using the chi-square test.
Results: Our results showed that the HPV infection rate in postmenopausal women in Nanjing, China was 22.36%. In terms of age group, the infection rate was 19.54%, 24.30%, 26.58%, and 14.99% in those aged ≤ 50, 51-60, 61-70, and ≥ 71 years, respectively. The most common HPV subtypes were HPV52 (22.1 3%), HPV58 (15.86%), HPV53 (14.17%), HPV16 (12.61%), and HPV81 (11.66%), in that order. The single-HPV infection rate was 14.23%, and the multiple-genotype infection rate was 8.14% (1189/14,608).
Conclusions: This study showed that in Nanjing, China, the different age groups of post-menopausal women could have different rates of HPV infection, and the most common types were HPV52, HPV58, HPV53, HPV16 and HPV81. These findings highlighted the importance of understanding the epidemiology of HPV infection in specific populations, such as postmenopausal women in Nanjing, China. The results could provide valuable information for healthcare professionals and policymakers to develop targeted prevention and screening strategies for reducing the burden of HPV-related diseases in this population.
Keywords: Cervical cancer; Chinese women; Genotypes; HPV infection; Postmenopausal women.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.Front Public Health. 2024 Mar 21;12:1332696. doi: 10.3389/fpubh.2024.1332696. eCollection 2024. Front Public Health. 2024. PMID: 38590815 Free PMC article.
-
Human Papilloma Virus Infection and Gene Subtypes Analysis in Women Undergoing Physical Examinations: A 2015-2020 Study in Wenzhou, China.Cancer Control. 2024 Jan-Dec;31:10732748241257902. doi: 10.1177/10732748241257902. Cancer Control. 2024. PMID: 38783796 Free PMC article.
-
Patterns of Co-infection of HPV52 With Other HPV Genotypes and Their Risks of Cervical Precancer and Carcinoma.J Med Virol. 2025 Apr;97(4):e70312. doi: 10.1002/jmv.70312. J Med Virol. 2025. PMID: 40243019 Free PMC article.
-
Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women.Arch Gynecol Obstet. 2023 Jul;308(1):35-41. doi: 10.1007/s00404-022-06653-7. Epub 2022 Jul 29. Arch Gynecol Obstet. 2023. PMID: 35904609 Review.
-
Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.Arch Gynecol Obstet. 2020 Dec;302(6):1329-1337. doi: 10.1007/s00404-020-05787-w. Epub 2020 Sep 10. Arch Gynecol Obstet. 2020. PMID: 32914222 Free PMC article. Review.
Cited by
-
Multicenter study on the distribution and prevalence of human papillomavirus types in Hangzhou, Zhejiang from 2017 to 2023.Sci Rep. 2025 Mar 18;15(1):9374. doi: 10.1038/s41598-025-92102-9. Sci Rep. 2025. PMID: 40102507 Free PMC article.
-
Study on the detection rate, genetic polymorphism, viral load, persistent infection capacity, and pathogenicity of human papillomavirus type 33.Virol J. 2025 Apr 26;22(1):121. doi: 10.1186/s12985-025-02752-4. Virol J. 2025. PMID: 40287740 Free PMC article.
-
Age-related distribution of human papillomavirus genotypes in women with cervical squamous cell carcinoma from Linyi, China, 2015-2023.Virol J. 2025 May 22;22(1):157. doi: 10.1186/s12985-025-02790-y. Virol J. 2025. PMID: 40405259 Free PMC article.
References
-
- Muñoz N, Castellsagué X, Berrington de González A, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24(Suupl 3):31–10. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical